NBIX - Company ID 0000914475
The table below shows NEUROCRINE BIOSCIENCES INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $266.50M | $340.20M | $264.00M | $194.10M | $349.10M | $139.70M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $768.10M | $728.00M | $595.70M | $516.00M | $481.10M | $468.20M |
| Inventory | $64.50M | $69.30M | $56.90M | $59.10M | $45.80M | $42.50M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.44B |
| $2.16B |
| $1.75B |
| $1.64B |
| $1.88B |
| $1.67B |
| Property, plant & equipment | $90.90M | $97.30M | $91.70M | $87.00M | $80.00M | $80.10M |
| Goodwill | - | - | - | - | $6.10M | $5.70M |
| Total assets | $4.91B | $4.27B | $3.89B | $3.69B | $3.54B | $3.31B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $831.70M | $638.00M | $546.30M | $522.90M | $429.70M | $398.50M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.50B | $1.26B | $1.20B | $1.15B | $816.10M | $795.80M |
| Retained earnings | $589.60M | $294.00M | $84.50M | -$5.30M | $81.10M | -$48.70M |
| Total equity | $3.41B | $3.00B | $2.69B | $2.54B | $2.72B | $2.51B |